(?S)-?-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8; (?S)-?-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8; PR 171-d8
Carfilzomib-d8 is a fully characterized chemical compound used as a reference standard of API Carfilzomib. The standard offered is compliant with regulatory guidelines. Carfilzomib-d8 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1537187-53-3
Related products
(S)-2-amino-4-oxo-4-phenylbutanoic acid hydrochloride)
M.F. C₁₀H₁₁NO₃ . HCl
M.W. 193.20 36.46
CAT# AR-C01418
CAS# 168154-76-5
Carfilzomib Impurity 13 HCl
M.F. C₁₆H₂₂N₂O₄. HCl
M.W. 306.36 36.46
CAT# AR-C01431
CAS# 1396006-45-3 (free base)
Benzyl ((S)-2-amino-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate
M.F. C₃₂H₃₉N₃O₄
M.W. 529.68
CAT# AR-C05312
CAS# 875309-82-3
